News & Media
Diplomat Named Exclusive Specialty Partner for Hospitality Rx
FLINT, Mich. — Jan. 7, 2019 — Diplomat Pharmacy, Inc. (NYSE: DPLO), has been selected by Hospitality Rx as the exclusive provider of specialty pharmacy and infusion services for its UNITE HERE HEALTH (UHH) plan members.
UHH is a multiemployer union plan that provides health benefits to approximately 250,000 members across the nation. Pharmacy benefit management services for most UHH markets are provided by UHH subsidiary Hospitality Rx.
“Diplomat is proud to have earned the trust of Hospitality Rx and UHH,” said Robyn Peters, executive vice president of sales and payer strategies. “This partnership means more patients — especially those dealing with complex and chronic conditions — will have access to highly skilled teams who truly understand their needs.”
As part of the agreement, Diplomat will provide services including specialty product fulfillment, reimbursement support, clinical assistance and adherence programs, and data reporting and analytics.
“We believe our success — and the health of our plan members — depends on innovation and strong partnerships,” said Matthew Walker, chief executive officer of UHH. “We partnered with Diplomat to enhance our ability to deliver high-quality care at a great value for our participants.”
To learn more about Diplomat, visit diplomat.is.
This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements give current expectations or forecasts of future events or our future financial or operating performance. The forward-looking statements contained in this press release are based on management’s good-faith belief and reasonable judgment based on current information. These statements are qualified by important risks and uncertainties, many of which are beyond our control, that could cause our actual results to differ materially from those forecasted or indicated by such forward-looking statements. For a discussion of such risks and uncertainties, you should review Diplomat’s filings with the Securities and Exchange Commission, including “Risk Factors” in Diplomat’s Annual Report on Form 10-K for the year ended Dec. 31, 2017, and in subsequent reports filed with or furnished to the Securities and Exchange Commission. Except as may be required by any applicable laws, Diplomat assumes no obligation to publicly update such forward-looking statements, which are made as of the date hereof or the earlier date specified herein, whether as a result of new information, future developments, or otherwise.
Diplomat (NYSE: DPLO) is the nation’s largest independent provider of specialty pharmacy and infusion services. Diplomat helps people with complex and chronic health conditions in all 50 states, partnering with payers, providers, hospitals, manufacturers, and more. Rooted in this patient care expertise, Diplomat also serves payers through CastiaRx, a leading specialty benefit manager, and offers tailored solutions for healthcare innovators through EnvoyHealth. Diplomat opened its doors in 1975 as a neighborhood pharmacy with one essential tenet: “Take good care of patients and the rest falls into place.” Today, that tradition continues — always focused on improving patient care. For more information, visit diplomat.is.
About UNITE HERE HEALTH
UNITE HERE HEALTH is a multi-employer Taft-Hartley Trust Fund governed by a Board of Trustees composed of union and employer representatives. Our mission is to provide health benefits that offer high-quality, affordable healthcare to our participants at better value with better service than is otherwise available in the market. We believe our success depends on innovation and on engaging our participants. For more information, visit uhh.org.